April Group has announced that its international healthcare has increased by 7% to €90m (£77.8m) in turnover.
That growth was a part its overall turnover of €860m, an increase of 36%.
April said that it had met its growth targets, one year after launching its strategic plan.
Last year, Health & Protection reported that the April Group had set a goal of exceeding turnover of more than £850m (€1bn) in three years time with an “internationalisation” across all its markets – starting with international health, and “strong” ambitions in Europe, the Middle East and Asia.
April said: “With 36% growth, April reaffirms its ambition to become Europe’s leading world-class insurance broker in the mass market.”
The company said a total of its 21% of turnover was recorded outside of France. It plans to increase that to 30% by 2027.
April International also announced that its ambition of having a single global information system will become a reality in 2025, delivering a major competitive advantage amid a phase of consolidation in the international healthcare market.
April’s personal insurance activities, including health and protection of consumers, professionals and businesses, and creditor insurance – grew by 2% over the period to €358m.
April noted: “The consumer healthcare market recovered in the final quarter, and should sustain the high performance of the group’s business healthcare activities.
The group said that its four market segments including international health insurance personal insurance, property and casualty insurance, and asset management – are growing.
Some 400 employees will be hired in 2025, with the focus being customer-relationship, digital and IT roles.
Latitude and resources
Eric Maumy, CEO of the April Group (pictured) said: “April’s solid results reflect our partners’ and customers’ trust as well as our teams’ commitment.
“The first two years of our strategic partnership with KKR have proved a success that is consolidating our joint ambition of making April a world-class European player.
“Our stable, long-term shareholder base gives us the latitude and resources to continue and accelerate the transformation and expansion that we’ve embarked on, and we fully intend to do this.
“More specifically, although France is our biggest market and we are enjoying sustained development there, our target is to generate 30% of our turnover internationally by 2027.
“This will involve large external-growth transactions in high-value-added business lines in addition to those where we already operate – and especially in international healthcare, where our development engine is powering up.
“One last point: we will remain a strong voice defending consumers’ interests, particularly in creditor insurance, where we will be making representations to the authorities and to members of parliament in the face of anti-competitive practices by certain bancassurance insurers.”
